Pharmaceutical Sector
(Healthcare)

Pharmaceutical Sector Experience

Over 350 projects delivered, covering 25+ segments of the pharmaceutical sector in 45+ countries

Prescription Drug categories

  • Oncology
  • Anti-diabetics
  • Anti-rheumatics
  • Dental and Oral Health
  • Dermatology
  • Endocrinology
  • Anti-hypertensives
  • Dermatologicals
  • Gastroenterology
  • Hematology
  • Orthopedics
  • Urology
  • Immunology
  • Infectious diseases
  • Nephrology
  • Cardiology
  • Respiratory diseases
  • Neurology

OTC Drug categories

  • Antacid
  • Topical anti-fungal
  • Antiemetic
  • Cough and cold
  • Internal analgesics
  • Ophthalmic

Other categories

  • Homeopathy medicine
  • Naturopathy
  • Ayurvedic medicine
  • Chinese medicine
  • Other alternative medicine
Assignment Examples

Explore our work in the Pharmaceuticals sector across the world


    • Attractive segment identification in Japan's pharmaceutical sector
    • Biotechnology policy formulation for a leading Indian state
    • Study on the Chinese OTC drug Market: Evolution from Rx-to-OTC
    • Competitor intelligence on infectious diseases drug penetration in Indonesia
    • Market Study on API and Medicine Intermediates in Vietnam
    • Impact assessment of alternate medicines on Bangladesh’s pharmaceutical sector
    • Identification and classification of pharmaceutical manufacturing plants in India
    • Identify drug development opportunities driven by aging population in Australia

    • Feasibility study on Iran's generic pharmaceutical sector
    • Opportunity Analysis in Israel's Biosimilars Market
    • Route to market strategy for setting up a peptide drug market in Saudi Arabia
    • Opportunity identification for manufacturing off patent drugs in UAE
    • Assessing the distribution potential for an anti-infectives hub in Bahrain
    • Market share analysis of leading Type 2 Diabetes drug companies in GCC
    • Generic drug manufacturing feasibility in UAE
    • Potential for drug exports that cater to Jordan's blooming medical tourism market

    • Mapping disease incidence, drug potential for neuropsychiatric illnesses in Egypt
    • Market overview of the branded pharmaceutical drug market in Ethiopia
    • Mapping Algeria's communicable disease burden and potential for a new entrant
    • Transfer pricing strategy for an antibiotic manufacturing firm in Tanzania
    • Prescription drug market overview in Kenya
    • Mapping the demand-supply gap for Ebola vaccines in Guinea
    • Market size estimation for yellow fever drugs in Angola
    • Competitive analysis of other African drug companies in Sudan

    • Opportunity assessment for API manufacturing in Russia
    • Feasibility study for setting up a generics manufacturing plant in Turkey
    • Mapping expansion plans of pharmaceutical companies in Finland
    • Strategic Assessment of biosimilars partnership of two leading players in UK
    • White space analysis for food bio-preservatives in France
    • Opportunity analysis and entry options for Alzheimer's disease in Germany
    • Updating and maintaining an online portal on Western European drug manufacturers
    • Feasibility study for setting up CRO service across therapeutic areas in Poland

    • Market study on the specialty drug market in the US
    • Generic Drugs market study in Canada to identify key segments by therapeutic areas
    • Competitor analysis for an oncology drug manufacturer exporting to Mexico
    • Competitor benchmarking of branded drug manufacturers in the US
    • Investment attractiveness assessment Canada's Biotechnology Market
    • Fertility Drugs Payment Analysis in the US
    • Assessing the business opportunity for Microbiota Defined Models in the US
    • Marketing, distribution and sales strategies for orphan drugs in the US

    • Feasibility study on hormonal contraceptives market in Paraguay
    • PESTLE analysis for setting up a drug manufacturing facility in Venezuela
    • Vaccine Schedules and Concomitancy Research in Dengue Endemic Market in Brazil
    • Identifying opportunities in degenerative related diseases in Brazil
    • Distribution strategy for imported generic drugs in Chile
    • Dipstick surveys to analyze Colombia's clinical research offerings
    • Country comparison of Cuban biotech industry to other emerging markets
    • Market study on the branded generic drug industry in Venezuela

Case Studies

Global Market Study on the Propofol Market

Read More

Case Study

Global Market Study on the Propofol Market

Background

A global consulting firm engaged Aranca to conduct a global market study on Propofol–a general anaesthetic drug

Aranca Approach

Detailed analysis of the global Propofol market, key trends, market size, competitive landscape and market characteristics

Results

Our analysis helped the client identify the most attractive regions for Propofol and its market dynamics

Desk Research

Market size of Propofol (historical and forecasted) globally

Market share analysis of major players & company cost structure, detailed profiles of leading companies

Expert Interviews

Discussion with 30+ industry experts

Focus on manufacturing process for Propofol, cost structure, analysis of various processes employed and estimated costs

Analysis

Provide the global market size and competitive landscape for Propofol including detailed profiles of the major customers, key factors in supplier selection and buying process

Diversification opportunity assessment for large family group in MENA pharmaceutical sector

Read More

Case Study

Diversification opportunity assessment for large family group in MENA pharmaceutical sector

Background

A GCC-based family-owned conglomerate engaged Aranca to assess opportunity for pharmaceutical manufacturing in KSA, with a sales focus in the MENA region

Aranca Approach

Detailed analysis of the existing landscape, therapeutic area wise opportunity assessment, detailed business plan and route to market strategy

Results

Our analysis helped the client identify the market potential and develop the market entry strategy into the targeted segment within the pharmaceuticals sector in MENA

Ideate

Identify key industry parameters and metrics

Define framework for comparative analysis of business segments (by disease type) and locations to identify relevant opportunities

Desk Research

Detailed analysis of Pharmaceuticals sector in MENA: market size, trends, and regulatory framework

Identification of growth potential for different therapeutic areas

Expert Interviews

Discussion with ~20 industry experts and competitors across MENA region

Focus on operating model, revenue and cost drivers and challenges

Analysis

Shortlist the most attractive drugs for a deep dive feasibility and location analysis

Formulate the go-to-market strategy, with a key focus on target operating model and marketing channel

Trying to get answers about customers, competition, markets or technology?

Knowledge Library

    1
    2. 2
  2. AI Patent Race Among Global Leaders

    Artificial Intelligence (AI) is reshaping industries and revolutionizing the global economy. The surge in AI-related patents is a testament to its growing influence, with countries

    3. 3
  3. Effects of Non-Compliance of ASC 805 or IFRS 3

    Financial Accounting Standard (FAS) 141 was first implemented in 2001. It is now codified as ASC 805, Business Combinations. Business combinations mean the acquisition of one company by

  1. 1
  2. 2
  3. 3
    Plastics Reshaping Wearable Medical Devices

    Developments in medical technology have increased the demand for advanced materials and their use in various applications in the medical industry in everything from packaging

Decide Fearlessly
Aranca is a global research analytics and advisory firm with over 20 years of experience in helping organizations take strategic business and investment decisions fearlessly and with utmost conviction.
Connect with us
Reach out to us

© , Aranca. All rights reserved.